Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh Thevendran

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biotechnology Journal|February 15, 2026
Molecular Genetics as the Leading-Edge Approach in Driving the Development of Live Attenuated VaccinesRamesh Thevendran, Solayappan Maheswaran
Talanta|December 3, 2021
Assays to Estimate the Binding Affinity of AptamersRamesh Thevendran, Marimuthu Citartan
Biotechnology Journal|May 14, 2023
Recognizing CRISPR as the new age disease-modifying drug: Strategies to bioengineer CRISPR/Cas for direct in vivo deliveryRamesh Thevendran, Solayappan Maheswaran
Analytical Biochemistry|December 24, 2024
In silico selection against progesterone receptor DNA-binding domainTholasi Nadhan Navien, Ramesh Thevendran, Marimuthu Citartan
Biotechnology Journal|February 3, 2023
In-silico selection employing rigid docking and molecular dynamic simulation in selecting DNA aptamers against androgen receptorRamesh Thevendran, Thean-Hock Tang, Marimuthu Citartan
SAGE Open Medical Case Reports|February 24, 2026
Purification and antibody-free ex-vivo expansion of peripheral blood-derived autologous natural killer cells: A Malaysian case series on patient safety and tolerabilityRamesh Thevendran, Manickam Ravichandran, Seng Kong Tham
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2020
Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A reviewRamesh Thevendran, Shigdar Sarah, Thean-Hock Tang, et al.
Molecular Biotechnology|July 31, 2024
Prospects of Innovative Therapeutics in Combating the COVID-19 PandemicThamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Biotechnology Journal|May 4, 2023
Spiked nanorosette: A novel zinc oxide-gold textured nanostructure for impedance biosensing of target DNA signaturesRajintra Prasad Haarindraprasad, Nathan Thurga Devi, Ramesh Thevendran, et al.
Molecular Biology Reports|April 9, 2025
Studying the cellular efficacy and tolerability of using CRISPR-gRNA ribonucleoprotein (RNP) complex for in-vitro knockdown of TRIB2 in acute myeloid leukaemia (AML) cells as preliminary clinical evaluationsJosephine You Pheng Tan, Ramesh Thevendran, Yek Song Quek, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biotechnology Journal|February 15, 2026
Molecular Genetics as the Leading-Edge Approach in Driving the Development of Live Attenuated VaccinesRamesh Thevendran, Solayappan Maheswaran
Talanta|December 3, 2021
Assays to Estimate the Binding Affinity of AptamersRamesh Thevendran, Marimuthu Citartan
Biotechnology Journal|May 14, 2023
Recognizing CRISPR as the new age disease-modifying drug: Strategies to bioengineer CRISPR/Cas for direct in vivo deliveryRamesh Thevendran, Solayappan Maheswaran
Analytical Biochemistry|December 24, 2024
In silico selection against progesterone receptor DNA-binding domainTholasi Nadhan Navien, Ramesh Thevendran, Marimuthu Citartan
Biotechnology Journal|February 3, 2023
In-silico selection employing rigid docking and molecular dynamic simulation in selecting DNA aptamers against androgen receptorRamesh Thevendran, Thean-Hock Tang, Marimuthu Citartan
SAGE Open Medical Case Reports|February 24, 2026
Purification and antibody-free ex-vivo expansion of peripheral blood-derived autologous natural killer cells: A Malaysian case series on patient safety and tolerabilityRamesh Thevendran, Manickam Ravichandran, Seng Kong Tham
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 8, 2020
Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A reviewRamesh Thevendran, Shigdar Sarah, Thean-Hock Tang, et al.
Molecular Biotechnology|July 31, 2024
Prospects of Innovative Therapeutics in Combating the COVID-19 PandemicThamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Biotechnology Journal|May 4, 2023
Spiked nanorosette: A novel zinc oxide-gold textured nanostructure for impedance biosensing of target DNA signaturesRajintra Prasad Haarindraprasad, Nathan Thurga Devi, Ramesh Thevendran, et al.
Molecular Biology Reports|April 9, 2025
Studying the cellular efficacy and tolerability of using CRISPR-gRNA ribonucleoprotein (RNP) complex for in-vitro knockdown of TRIB2 in acute myeloid leukaemia (AML) cells as preliminary clinical evaluationsJosephine You Pheng Tan, Ramesh Thevendran, Yek Song Quek, et al.
Pageof 2